Skip to main content

and
  1. No Access

    Article

    Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases

    Systemic inflammatory and autoimmune diseases (SIADs) occur in 10–20% of patients with myelodysplastic syndrome (MDS). Recently identified VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndr...

    Vincent Jachiet, Laure Ricard, Pierre Hirsch in Clinical and Experimental Medicine (2023)

  2. Article

    Open Access

    French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes

    Eosinophilic-related clinical manifestations are protean and the underlying conditions underpinning eosinophilia are highly diverse. The etiological workup of unexplained eosinophilia/hypereosinophilia can be ...

    Matthieu Groh, Julien Rohmer, Nicolas Etienne in Orphanet Journal of Rare Diseases (2023)

  3. Article

    Correction to: Protein‑losing Enteropathy as a Complication and/or Differential Diagnosis of Common Variable Immunodeficiency

    Sébastien Sanges, Nicolas Germain, Stéphane Vignes in Journal of Clinical Immunology (2023)

  4. No Access

    Article

    A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML

    Arsene Mekinian, Lin Pierre Zhao, Sylvie Chevret, Kristell Desseaux in Leukemia (2022)

  5. No Access

    Article

    Protein-losing Enteropathy as a Complication and/or Differential Diagnosis of Common Variable Immunodeficiency

    As protein-losing enteropathy (PLE) can lead to hypogammaglobulinemia and lymphopenia, and since common variable immunodeficiency (CVID) is associated with digestive complications, we wondered if (1) PLE could...

    Sébastien Sanges, Nicolas Germain, Stéphane Vignes in Journal of Clinical Immunology (2022)

  6. No Access

    Article

    Haemophagocytic lymphohistiocytosis following allogeneic hematopoietic cell transplantation from mismatched unrelated donors associated with low CD34 and CD3 cell counts in the graft

    Nicolas Gower, Valérie Coiteux, Micha Srour, Léonardo Magro in Bone Marrow Transplantation (2022)

  7. No Access

    Article

    Tolerance of bradykinin-releasing drugs in patients with acquired C1 inhibitor deficiency: a case series and review of the literature

    As acquired angioedema (AAE) usually occurs in elder patients, the use of angiotensin converting enzyme inhibitors (ACEi), angiotensin receptor blockers (ARB) and dipeptidyl peptidase 4 inhibitors (DPP-4i) may...

    Guillaume Escure, Morgane Nudel, Louis Terriou in European Journal of Dermatology (2022)

  8. No Access

    Article

    Long term outcomes of the French ASTIS systemic sclerosis cohort using the global rank composite score

    Two randomised trials (ASTIS, SCOT) of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) versus monthly Cyclophosphamide for severe Systemic Sclerosis (SSc) patients used similar inclusion criteria, b...

    Nassim Ait Abdallah, Mianbo Wang, Pauline Lansiaux in Bone Marrow Transplantation (2021)

  9. No Access

    Article

    Nationwide survey in France on the use of romiplostim in patients with refractory severe aplastic anemia

    Lin-Pierre Zhao, Flore Sicre De Fontbrune, Adrien Contejean in Bone Marrow Transplantation (2019)

  10. No Access

    Article

    Autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease adult patients in France: analysis of the long-term outcome from the French Society for Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

    The use of autologous haematopoietic stem cell transplantation (AHSCT) in autoimmune disease (AD) patients has increased progressively worldwide. We retrospectively analysed the long-term outcome of AHSCT for ...

    Perrine Guillaume-Jugnot, Manuela Badoglio, Myriam Labopin in Clinical Rheumatology (2019)

  11. No Access

    Article

    Paroxysmal nocturnal hemoglobinuria (PNH) and T cell large granular lymphocyte (LGL) leukemia—an unusual association: another cause of cytopenia in PNH

    Thomas Boyer, Nathalie Grardel, Marie-Christine Copin in Annals of Hematology (2015)

  12. No Access

    Article

    Phase 1 study of the oral histone deacetylase inhibitor abexinostat in patients with Hodgkin lymphoma, non-Hodgkin lymphoma, or chronic lymphocytic leukaemia

    Background We determined the safety, pharmacokinetics, pharmacodynamics, and antitumour activity of abexinostat in B-cell lymphoma or chronic lymphocytic leukaemia. Patients and methods Thirty-fi...

    Franck Morschhauser, Louis Terriou, Bertrand Coiffier in Investigational New Drugs (2015)

  13. No Access

    Article

    Detection of Non-Hodgkin’s Lymphoma in ovarian cortex pieces during the process of cryopreservation

    Héloïse Gronier, Louis Terriou in Journal of Assisted Reproduction and Genet… (2014)

  14. No Access

    Article

    Long-term outcome in acquired aplastic anemia treated with an intensified dose schedule of horse antilymphocyte globulin in combination with androgens

    Aplastic anemia (AA) is a rare hematopoietic stem cell disease, which can be treated with horse antilymphocyte globulin (ALG) for patients not eligible for bone marrow transplantation. ALG gives about 60% over...

    Xavier Leleu, Louis Terriou, Alain Duhamel, Anne-Sophie Moreau in Annals of Hematology (2006)

  15. No Access

    Article

    Conversion from Mycophenolate Mofetil to Enteric-coated Mycophenolate Sodium (myfortic®) in a Patient with Graft-versus-host Disease

    Frédérique Kuhnowski, Louis Terriou, Leonardo Magro, Jean-Pierre Jouet in Drugs (2006)